Long-term clopidogrel therapy in the drug-eluting stent era: beyond CREDO and PCI-CURE.
نویسنده
چکیده
Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. JACC 2002;40:1615–22. 5. Cazeau S, Bordacher P, Jauvert A et al. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation. PACE 2003;26:1–7. 6. Yu CM, Fung WH, Lin H et al. Predictors of left ventricular reverse remodeling after ischemic cardiomyopathy. Am J Cardiol 2002;91(6): 684–8.
منابع مشابه
Drug-eluting stents.
In their recent systematic review, Suzanne Ligthart and associates compared analyses of the cost-effectiveness of drug-eluting stents. They found that in most studies in which an incremental cost-effectiveness ratio greater than $50 000 per quality-adjusted life-year was calculated the study authors recommended against the widespread use of drug-eluting stents. However, we believe that previous...
متن کاملAspirin and Clopidogrel Resistance in Drug Eluting Stent Era
Platelets play a central role in the pathogenesis of atherothrombosis. Dual antiplatelet therapy with clopidogrel plus aspirin has been shown to reduce ischemic events in patients undergoing percutaneous coronary intervention (PCI) and stenting. Although dual antiplatelet therapy reduces the risk of cardiovascular episodes after PCIs, a substantial number of incidents continue to occur. Many ca...
متن کاملAspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
Patients undergoing coronary artery stenting receive an antiplatelet regimen to reduce the risk of antithrombotic complications. Current guidelines recommend the use of acetyl salicylic acid (aspirin) and clopidogrel as evidenced by large clinical trials. There has been a concern about variable responses of patients to aspirin and clopidogrel which may predispose them to subacute stent thrombos...
متن کاملWhy we need a national registry in interventional cardiology.
Percutaneous coronary intervention (PCI) is increasingly used in the management of acute coronary syndromes and refractory angina, and technical advances such as drug-eluting stents (DES) and potent antithrombotic therapies (such as clopidogrel and glycoprotein IIb/IIIa inhibitors) have been heralded as improving long-term outcomes. Offsetting these advances has been: considerable concern about...
متن کاملClopidogrel Resistance is Associated with Long-Term Thrombotic Events in Patients Implanted with Drug-Eluting Stents
BACKGROUND There are limited prospective data on clopidogrel resistance and clinical outcome of patients with selective coronary drug-eluting stent (DES) implantation. OBJECTIVE To investigate whether clopidogrel resistance is associated with long-term thrombotic events in patients with selective coronary DES implantation. METHODS A total of 154 patients who underwent selective percutaneous...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European heart journal
دوره 25 15 شماره
صفحات -
تاریخ انتشار 2004